CompletedNot Applicable

Short-Term Effects of an AI-Based Wearable Adherence Monitor in Outpatient Psychiatry

South Korea78 participantsStarted 2022-12-31

Plain-language summary

Medication nonadherence undermines treatment effectiveness in psychiatric care, yet objective measurement in routine practice remains challenging. AI-enabled wearables may offer scalable monitoring, but evidence from randomized evaluations is limited. This exploratory trial evaluated the short-term effect of an AI-enabled smartwatch intervention on clinician-assessed medication adherence in adolescent and young adult psychiatric outpatients.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 12 years or older * Receiving outpatient psychiatric care at the Department of Psychiatry * Willing to wear a study smartwatch and undergo study assessments * Able to provide written informed consent (or assent with parental consent for minors) Exclusion Criteria: * Age under 12 years * Diagnosed with congenital genetic disorders * Clear history of acquired brain injury (e.g., cerebral palsy, cerebral infarction) * Comorbid seizure disorders or other neurological conditions * Severe psychotic symptoms or aggression precluding safe and stable smartwatch use or posing risk of device damage

What they're measuring

Change in Brief Adherence Rating Scale (BARS) Score

Timeframe: Baseline (pre-randomization 28-day window) and end of intervention (28-day post-intervention window, week 4)

Trial details

NCT IDNCT07455916

SponsorWonkwang University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Mental Disease trials